Takeda posts results for TAK-881 vs HYQVIA pharmacokinetic study in PIDD patientsSep 30Trial updateTakeda Pharmaceutical Co Ltd
Takeda terminates GDX012 AML trial by sponsor decision; results postedSep 25Trial updateTakeda Pharmaceutical Co Ltd
Takeda's GATTEX gets REMS-related supplement approved by FDAAug 26Regulatory decisionTakeda Pharmaceutical Co Ltdteduglutide
Takeda gets FDA labeling approvals for Actoplus Met and KazanoAug 11Weekly roundup, 2 itemsalogliptin and metformin hydrochloridepioglitazone and metformin hydrochloride
FDA approves Takeda's Orzeyful for new molecular entity applicationAug 5Regulatory decisionoveporextonTakeda Pharmaceutical Co Ltd
Sign in